MEDIPLAST AS

Org. no. 988598348 · DRAMMEN · Founded 2005 · 10 employees

Score · fiscal year 2025

48of 100

How to read this: the company is ahead of 47 % of companies in the Morning class Medium in the same sector in 2025. What does this mean?

Rank in the Morning class Medium: 1,980 of 3,712 · What are Morning company classes?
Place in the whole sector: 12,492 of 23,059 · Handel

Profile

Cheetah · Sprinter

High profitability, lower solidity

Position against comparable companies in 2025, not a verdict on the company. Based on profitability 83 and solidity 31 out of 100 among companies in the Morning class Medium in the same sector in 2025. Methodology

Against the sector

MEDIPLAST AS is 2 points below the median for companies in the Morning class Medium in the same sector in 2025.

Median score 50 among 3,712 companies.

Against companies in the Morning class Medium in the same sector in 2025: operating margin 7.7% (median 3.0%) and equity ratio 20.7% (median 30.0%).

Source: Register of Company Accounts and Central Coordinating RegisterFetched 29 October 2026Report an issue
Key figures · 2025

The numbers behind the score

The numbers behind the score · 2025
MeasureCompanyMedianAhead of
Operating revenue144 MNOK93 MNOK
Operating margin 7.7% 3.0% 80 %
Profit margin 8.1% 2.8% shown, not part of the index
Return on assets 26.9% 11.6% 85 %
Equity ratio 20.7% 30.0% 32 %
Debt-to-equity 3.82 2.24 30 %
Current ratio 1.25 1.39 38 %
Revenue growth 0.3% 6.1% 28 %
Revenue per employee14.44 MNOK5.07 MNOK

The median and “ahead of” refer to companies in the Morning class Medium in the same sector in 2025. The bar shows the share of companies the figure is ahead of.

With an index of 48, MEDIPLAST AS does better than 47% of companies in the Morning class Medium in the same sector (3,712 companies) in 2025.

Over time

Score 2023–2025

CompanyMedian0255075100202320242025
  • MEDIPLAST AS
  • Median: companies in the Morning class Medium in the same sector
Summary analysis

MEDIPLAST AS has a score of 48 for 2025, rank 12,492 of 23,059 in the sector.

Strongest: Profitability: percentile 83 against peers, operating margin 7.7% against a median of 3.0%.

Weakest: Growth: percentile 28 against peers, revenue growth 0.3% against a median of 6.1%. Solidity: percentile 31 against peers, equity ratio 20.7% against a median of 30.0%.

Worth a closer look

Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made

Analysis · 2025

What the numbers say

MEDIPLAST AS had an operating margin of 7.7% and an equity ratio of 20.7% in 2025, and ranks 12,492 of 23,059 in Handel.

From 2024 to 2025: the equity ratio fell from 41.5% to 20.7%.

This text is generated automatically from the 2025 accounts.

Estimated value · 2025

Three simple methods

The methods give between 9 MNOK and 91 MNOK.

MethodInputMultipleEstimate
P/E Net profit: 9.1 MNOK 10.0 91 MNOK
EV/EBIT Operating profit: 11.1 MNOK
minus net debt −0.3 MNOK
8.0 89 MNOK
P/B Equity: 9.0 MNOK 1.0 9 MNOK

A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation

Indications · 2025

Worth a closer look

No rules were triggered for this year.

Indications based on the latest annual accounts from open data. Not investment or financial advice.

Financial costs were 0.1% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.

See interest rates, prices and exchange rates for the sector

Data quality

No anomalies found in the figures.

Stress test · 2022

Scenario analysis: the sector's weakest year

We have no accounts for 2022, the sector's weakest year, for this company.

The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology

Components · 2025

What the score is made of

Profitability83 weight 30%
Solidity31 weight 25%
Liquidity38 weight 15%
Growth28 weight 15%
Consistency38 weight 15%

Durability: 68 (average over 3 years)

Index version 2. Data completeness 100%: the share of the weights that had data.

2025

Questions and answers

How profitable is MEDIPLAST AS?

The operating margin was 7.7% in 2025, against a median of 3.0% among companies in the Morning class Medium in the same sector. Return on assets was 26.9%.

How solid is MEDIPLAST AS?

The equity ratio was 20.7% in 2025 (median 30.0%). Debt-to-equity was 3.82 (median 2.24).

What is the liquidity of MEDIPLAST AS like?

The current ratio was 1.25 in 2025 (median 1.39).

How does MEDIPLAST AS compare in Handel?

MEDIPLAST AS ranks 12,492 of 23,059 in Handel for 2025. Among companies in the Morning class Medium it is number 1,980 of 3,712. Revenue changed by 0.3% from the year before.

Public contracts

Contracts awarded since 2024
16
in 14 notices (lots counted separately)
Total awarded value since 2024
4.0 MNOK
1 contracts without a stated value are not in the total.
Framework agreements
14
Left out of the total: the value is a ceiling, not actual spend.
DateBuyerNotice ValueCPV
5 March 2026 SYKEHUSINNKJØP HF Kontraktstildeling: Thoraxdrenasje og pleuratappesett til sykehusene i Helse Vest 8.5 MNOK (framework) 33141600
19 November 2025 SYKEHUSINNKJØP HF Kontraktstildeling: Ortopedisk sug/spyl og sugesett engangs til sykehusene i Helse Sør-Øst 0.6 MNOK (framework) 33141700
7 July 2025 SYKEHUSINNKJØP HF Hemodialysebehandling utstyr og maskiner til helseforetakene i Norge 460.0 MNOK (framework) 33600000
1 July 2025 SYKEHUSINNKJØP HF Fibroscan til Helse Stavanger HF - Kontraktsinngåelse med Mediplast AS 4.0 MNOK 33100000
31 March 2025 SYKEHUSINNKJØP HF Kontraktstildeling: Respirasjon-overvåkning og generell oksygenbehandlling for foretakene i Helse Vest 2.7 MNOK (framework) 33140000
12 March 2025 SYKEHUSINNKJØP HF Kontraktstildeling: Prosedyrepakker til helseforetakene i Helse Nord value not stated 33140000
5 February 2025 SYKEHUSINNKJØP HF Prosedyrepakker til radiologi og kardiologi til helseforetak i Helse Vest value not stated 33141600
14 January 2025 SYKEHUSINNKJØP HF Oppdekkingssett og operasjonsoppdekking til helseforetakene i Helse Nord value not stated 39518200
12 December 2024 SYKEHUSINNKJØP HF Sterile trekk til medisinsk utstyr til foretakene i Helse Vest value not stated 33140000
12 December 2024 SYKEHUSINNKJØP HF Kontraktstildeling: Operasjonshansker til helseforetakene i Helse Midt-Norge value not stated 33000000

Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.

Source: Doffin (DFØ), fetched 28 October 2026. Winners are matched on organisation number.

Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0

From the Central Coordinating Register

Org. no.
988598348
Legal form
AS
Sector
Handel (46.460)
Morning company class
Medium
Employees
10 registered 10 December 2025
Founded
10 August 2005 21 years in operation
Share capital
1.00 MNOK
Business address
Bjørnstjerne Bjørnsons gate 110, 3044 DRAMMEN
Municipality
Drammen rank 10 of 11 in KOSTRA group 12
Latest accounts filed
2025
Website
www.mediplast.com

Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre

Ownership and roles

Chief executive
Johan Olof Mårten Bongstorp
Chair of the board
Anna Christina Rubenhag
Board member
Johan Olof Mårten Bongstorp
Board member
Rolf Ho Bornschein
Auditor
CEDRA NORGE AS
Accountant
PROGRESSUM AS
Accountant
ASPIA NORGE AS

Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.

Owners and shareholdings will appear here once the shareholder data extract is in place.

Coming · not built yet

Error in the data?

Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.

Report an issue

Figures last fetched 29 October 2026.

Details

Year by year · 2023–2025

Key figure202320242025Trend
Index867148
Rank9533,11012,492
Operating margin10.7%7.6%7.7%
Return on assets42.4%26.6%26.9%
Equity ratio54.7%41.5%20.7%
Current ratio2.191.681.25
Revenue growth–19.9%0.3%

Accounts

From the Brønnøysund Register Centre, in the company's reporting currency (NOK).

Key figure202320242025
Operating revenue120.2 MNOK144.1 MNOK144.4 MNOK
Operating profit12.8 MNOK10.9 MNOK11.1 MNOK
Profit before tax13.2 MNOK11.4 MNOK11.7 MNOK
Net profit10.3 MNOK8.9 MNOK9.1 MNOK
Financial expenses0.0 MNOK0.1 MNOK0.0 MNOK
Total assets31.1 MNOK43.2 MNOK43.5 MNOK
Current assets30.9 MNOK42.6 MNOK43.0 MNOK
Equity17.0 MNOK17.9 MNOK9.0 MNOK
Retained earnings15.7 MNOK16.6 MNOK7.7 MNOK
Total liabilities14.1 MNOK25.3 MNOK34.5 MNOK
Current liabilities14.1 MNOK25.3 MNOK34.5 MNOK

Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 29 October 2026, accounts id 6913608.

Similar companies